View in EDS

Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor.

Saved in:

Bibliographic Details
Title:	Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor.
Authors:	Smolinski MP; Athenex Inc., Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203, United States., Urgaonkar S; Athenex Inc., Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203, United States., Pitzonka L; Athenex Inc., Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203, United States., Cutler M; Athenex Inc., Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203, United States., Lee G; Hanmi Pharmaceutical Co. Ltd., 14, Wiryeseong-daero, Songpa-gu, Seoul, 05545, Korea., Suh KH; Hanmi Pharmaceutical Co. Ltd., 14, Wiryeseong-daero, Songpa-gu, Seoul, 05545, Korea., Lau JYN; Athenex Inc., Conventus Building, 1001 Main Street, Suite 600, Buffalo, New York 14203, United States.
Source:	Journal of medicinal chemistry [J Med Chem] 2021 Apr 08; Vol. 64 (7), pp. 3677-3693. Date of Electronic Publication: 2021 Mar 17.
Publication Type:	Journal Article
Journal Info:	Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1520-4804
DOI:	10.1021/acs.jmedchem.0c01826